Atypical presentations of thrombotic thrombocytopenic purpura: A review

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Thrombotic thrombocytopenic purpura (TTP) is diagnosed by the presence of microangiopathic hemolytic anemia and thrombocytopenia in a patient who frequently presents with central nervous system involvement and, to a lesser extent, renal dysfunction. Recent understanding of the pathophysiology of TTP due to severe deficiency of von Willebrand factor cleaving protease, known as ADAMTS13, has improved diagnosis of TTP. Once the diagnosis is suspected, life-saving therapeutic plasma exchange therapy is initiated. Occasionally, an unusual clinical presentation makes TTP diagnosis difficult, thus resulting in a delay in the management of TTP. This review highlights a variety of atypical TTP presentations described in the literature. It is intended to bring unusual scenarios to the clinician's awareness, so that timely treatment can be delivered.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalJournal of Clinical Apheresis
Volume24
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Thrombotic Thrombocytopenic Purpura
Plasma Exchange
Hemolytic Anemia
Thrombocytopenia
Therapeutics
Central Nervous System
Kidney

Keywords

  • Ccute MI
  • Rituximab
  • Stroke
  • Thrombotic thrombocytopenic purpura

ASJC Scopus subject areas

  • Hematology

Cite this

Atypical presentations of thrombotic thrombocytopenic purpura : A review. / Sarode, Ravi.

In: Journal of Clinical Apheresis, Vol. 24, No. 1, 2009, p. 47-52.

Research output: Contribution to journalArticle

@article{cf364e1ffa794173bb2e7024888ce852,
title = "Atypical presentations of thrombotic thrombocytopenic purpura: A review",
abstract = "Thrombotic thrombocytopenic purpura (TTP) is diagnosed by the presence of microangiopathic hemolytic anemia and thrombocytopenia in a patient who frequently presents with central nervous system involvement and, to a lesser extent, renal dysfunction. Recent understanding of the pathophysiology of TTP due to severe deficiency of von Willebrand factor cleaving protease, known as ADAMTS13, has improved diagnosis of TTP. Once the diagnosis is suspected, life-saving therapeutic plasma exchange therapy is initiated. Occasionally, an unusual clinical presentation makes TTP diagnosis difficult, thus resulting in a delay in the management of TTP. This review highlights a variety of atypical TTP presentations described in the literature. It is intended to bring unusual scenarios to the clinician's awareness, so that timely treatment can be delivered.",
keywords = "Ccute MI, Rituximab, Stroke, Thrombotic thrombocytopenic purpura",
author = "Ravi Sarode",
year = "2009",
doi = "10.1002/jca.20182",
language = "English (US)",
volume = "24",
pages = "47--52",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Atypical presentations of thrombotic thrombocytopenic purpura

T2 - A review

AU - Sarode, Ravi

PY - 2009

Y1 - 2009

N2 - Thrombotic thrombocytopenic purpura (TTP) is diagnosed by the presence of microangiopathic hemolytic anemia and thrombocytopenia in a patient who frequently presents with central nervous system involvement and, to a lesser extent, renal dysfunction. Recent understanding of the pathophysiology of TTP due to severe deficiency of von Willebrand factor cleaving protease, known as ADAMTS13, has improved diagnosis of TTP. Once the diagnosis is suspected, life-saving therapeutic plasma exchange therapy is initiated. Occasionally, an unusual clinical presentation makes TTP diagnosis difficult, thus resulting in a delay in the management of TTP. This review highlights a variety of atypical TTP presentations described in the literature. It is intended to bring unusual scenarios to the clinician's awareness, so that timely treatment can be delivered.

AB - Thrombotic thrombocytopenic purpura (TTP) is diagnosed by the presence of microangiopathic hemolytic anemia and thrombocytopenia in a patient who frequently presents with central nervous system involvement and, to a lesser extent, renal dysfunction. Recent understanding of the pathophysiology of TTP due to severe deficiency of von Willebrand factor cleaving protease, known as ADAMTS13, has improved diagnosis of TTP. Once the diagnosis is suspected, life-saving therapeutic plasma exchange therapy is initiated. Occasionally, an unusual clinical presentation makes TTP diagnosis difficult, thus resulting in a delay in the management of TTP. This review highlights a variety of atypical TTP presentations described in the literature. It is intended to bring unusual scenarios to the clinician's awareness, so that timely treatment can be delivered.

KW - Ccute MI

KW - Rituximab

KW - Stroke

KW - Thrombotic thrombocytopenic purpura

UR - http://www.scopus.com/inward/record.url?scp=63249107524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63249107524&partnerID=8YFLogxK

U2 - 10.1002/jca.20182

DO - 10.1002/jca.20182

M3 - Article

C2 - 19073011

AN - SCOPUS:63249107524

VL - 24

SP - 47

EP - 52

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 1

ER -